Skip to content

Enovis ENOV Reconstructive — Total Assets

Other segment segments

Prevention & Recovery
$1.45B

Similar metrics at other companies

UFP Industries, Inc. logo
UFPIConstruction — Total Assets
$649.18M-1.6%
Granite Construction logo
GVAConstruction — Total Assets
$688.11M+12.1%
Select Medical Holdings logo
SEMRehabilitation Hospital — Total Assets
$1.67B+18.7%
Arcosa logo
ACAConstruction Products — Total Assets
$3.36B+2.1%
New York Mortgage Trust logo
ADAMConstructive — Total Assets
$300.19M
Select Medical Holdings logo
SEMOutpatient Rehabilitation — Total Assets
$1.4B-1.3%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's reconstructive — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's reconstructive — total assets?
Enovis (ENOV) reported reconstructive — total assets of $2.38B in Q1 2026.
How has Enovis's reconstructive — total assets changed year-over-year?
Enovis's reconstructive — total assets decreased by 19.9% year-over-year, from $2.98B to $2.38B.
What does reconstructive — total assets mean?
This metric represents the total economic resources controlled by the Reconstructive segment, including property, plant, equipment, inventory, and intangible assets. It serves as a measure of the scale and capital base required to support the segment's medical device manufacturing and distribution operations. Tracking this helps assess the asset efficiency and return on capital employed.